Coston, McIsaac & Partners
Source: SEC Form 13F · as of Mar 2026Coston, McIsaac & Partners holds 8 biotech & pharma companies tracked by BioSniper, totaling $116 in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$116
BioSniper AIPage evidence connected
Prepared research question
What matters most for GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,361 | $75 |
| MRNAModerna, Inc. | 359 | $18 |
| GILDGILEAD SCIENCES, INC. | 119 | $16 |
| SNYSanofi | 105 | $5 |
| OGNOrganon & Co. | 372 | $2 |
| AVXLANAVEX LIFE SCIENCES CORP. | 200 | $0 |
| NWBONORTHWEST BIOTHERAPEUTICS INC | 1,000 | $0 |
| RXRXRECURSION PHARMACEUTICALS, INC. | 48 | $0 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.